Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study. Ayav, C., Beuscart, J., Briançon, S., Duhamel, A., Frimat, L., & Kessler, M. BMC nephrology, 17(1):174, November, 2016.
Paper doi abstract bibtex BACKGROUND: Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed. METHODS: From a community-based sample of 4,409 individuals residing in a well-defined geographical area, we determined the number of patients having a first serum creatinine value ≥1.7 mg/dL and present for at least 3 months that allowed us to calculate an annual incidence rate of CKD (stages 3 to 5). CKD (stages 3 to 5) was defined by estimated glomerular filtration rate (eGFR) \textless60 mL/min/1.73 m(2). We also described the primary care, outcomes and risk factors associated with outcomes using competing risks analyses for these CKD patients. RESULTS: A total of 631 incident CKD patients (stages 3 to 5) were followed-up until the occurrence of death and dialysis initiation for more than 3 years. The annual incidence rate of CKD (stages 3 to 5) was estimated at 977.7 per million inhabitants. Analyses were performed on 514 patients with available medical data. During the study, 155 patients (30.2 %) were referred to a nephrologist, 193 (37.5 %) died and 58 (11.3 %) reached end-stage renal disease and initiated dialysis. A total of 139 patients (27.6 %) had a fast decline of their renal function, 92 (18.3 %) a moderate decline and the 272 remaining patients had a physiological decline (21.1 %) or a small improvement of their renal function (33.0 %). Predictors of death found in both Cox and Fine-Gray multivariable regression models included age at diagnosis, anemia, active neoplasia and chronic heart failure, but not a low glomerular filtration rate (GFR). Age at diagnosis, anemia and a low GFR were independently associated with dialysis initiation in Cox model, but anemia was not found to be a risk factor for dialysis initiation in Fine-Gray model. CONCLUSIONS: This large cohort study provided useful epidemiological data on incident CKD (stages 3 to 5) and stressed the need to improve the hands-on implementation of clinical practice guidelines for the evaluation and the management of CKD in primary care.
@article{ayav_competing_2016,
title = {Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the {EPIRAN} community-based study},
volume = {17},
issn = {1471-2369},
shorttitle = {Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5)},
url = {https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-016-0379-3},
doi = {10.1186/s12882-016-0379-3},
abstract = {BACKGROUND: Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed.
METHODS: From a community-based sample of 4,409 individuals residing in a well-defined geographical area, we determined the number of patients having a first serum creatinine value ≥1.7 mg/dL and present for at least 3 months that allowed us to calculate an annual incidence rate of CKD (stages 3 to 5). CKD (stages 3 to 5) was defined by estimated glomerular filtration rate (eGFR) {\textless}60 mL/min/1.73 m(2). We also described the primary care, outcomes and risk factors associated with outcomes using competing risks analyses for these CKD patients.
RESULTS: A total of 631 incident CKD patients (stages 3 to 5) were followed-up until the occurrence of death and dialysis initiation for more than 3 years. The annual incidence rate of CKD (stages 3 to 5) was estimated at 977.7 per million inhabitants. Analyses were performed on 514 patients with available medical data. During the study, 155 patients (30.2 \%) were referred to a nephrologist, 193 (37.5 \%) died and 58 (11.3 \%) reached end-stage renal disease and initiated dialysis. A total of 139 patients (27.6 \%) had a fast decline of their renal function, 92 (18.3 \%) a moderate decline and the 272 remaining patients had a physiological decline (21.1 \%) or a small improvement of their renal function (33.0 \%). Predictors of death found in both Cox and Fine-Gray multivariable regression models included age at diagnosis, anemia, active neoplasia and chronic heart failure, but not a low glomerular filtration rate (GFR). Age at diagnosis, anemia and a low GFR were independently associated with dialysis initiation in Cox model, but anemia was not found to be a risk factor for dialysis initiation in Fine-Gray model.
CONCLUSIONS: This large cohort study provided useful epidemiological data on incident CKD (stages 3 to 5) and stressed the need to improve the hands-on implementation of clinical practice guidelines for the evaluation and the management of CKD in primary care.},
language = {eng},
number = {1},
journal = {BMC nephrology},
author = {Ayav, Carole and Beuscart, Jean-Baptiste and Briançon, Serge and Duhamel, Alain and Frimat, Luc and Kessler, Michèle},
month = nov,
year = {2016},
pmid = {27846810},
pmcid = {PMC5111196},
keywords = {Competing-risk analysis, Epidemiological study, Incidence, Outcomes, Risk Factors, chronic kidney disease},
pages = {174},
}
Downloads: 0
{"_id":"9yx8cD5gQ4DksR78N","bibbaseid":"ayav-beuscart-brianon-duhamel-frimat-kessler-competingriskofdeathandendstagerenaldiseaseinincidentchronickidneydiseasestages3to5theepirancommunitybasedstudy-2016","author_short":["Ayav, C.","Beuscart, J.","Briançon, S.","Duhamel, A.","Frimat, L.","Kessler, M."],"bibdata":{"bibtype":"article","type":"article","title":"Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study","volume":"17","issn":"1471-2369","shorttitle":"Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5)","url":"https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-016-0379-3","doi":"10.1186/s12882-016-0379-3","abstract":"BACKGROUND: Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed. METHODS: From a community-based sample of 4,409 individuals residing in a well-defined geographical area, we determined the number of patients having a first serum creatinine value ≥1.7 mg/dL and present for at least 3 months that allowed us to calculate an annual incidence rate of CKD (stages 3 to 5). CKD (stages 3 to 5) was defined by estimated glomerular filtration rate (eGFR) \\textless60 mL/min/1.73 m(2). We also described the primary care, outcomes and risk factors associated with outcomes using competing risks analyses for these CKD patients. RESULTS: A total of 631 incident CKD patients (stages 3 to 5) were followed-up until the occurrence of death and dialysis initiation for more than 3 years. The annual incidence rate of CKD (stages 3 to 5) was estimated at 977.7 per million inhabitants. Analyses were performed on 514 patients with available medical data. During the study, 155 patients (30.2 %) were referred to a nephrologist, 193 (37.5 %) died and 58 (11.3 %) reached end-stage renal disease and initiated dialysis. A total of 139 patients (27.6 %) had a fast decline of their renal function, 92 (18.3 %) a moderate decline and the 272 remaining patients had a physiological decline (21.1 %) or a small improvement of their renal function (33.0 %). Predictors of death found in both Cox and Fine-Gray multivariable regression models included age at diagnosis, anemia, active neoplasia and chronic heart failure, but not a low glomerular filtration rate (GFR). Age at diagnosis, anemia and a low GFR were independently associated with dialysis initiation in Cox model, but anemia was not found to be a risk factor for dialysis initiation in Fine-Gray model. CONCLUSIONS: This large cohort study provided useful epidemiological data on incident CKD (stages 3 to 5) and stressed the need to improve the hands-on implementation of clinical practice guidelines for the evaluation and the management of CKD in primary care.","language":"eng","number":"1","journal":"BMC nephrology","author":[{"propositions":[],"lastnames":["Ayav"],"firstnames":["Carole"],"suffixes":[]},{"propositions":[],"lastnames":["Beuscart"],"firstnames":["Jean-Baptiste"],"suffixes":[]},{"propositions":[],"lastnames":["Briançon"],"firstnames":["Serge"],"suffixes":[]},{"propositions":[],"lastnames":["Duhamel"],"firstnames":["Alain"],"suffixes":[]},{"propositions":[],"lastnames":["Frimat"],"firstnames":["Luc"],"suffixes":[]},{"propositions":[],"lastnames":["Kessler"],"firstnames":["Michèle"],"suffixes":[]}],"month":"November","year":"2016","pmid":"27846810","pmcid":"PMC5111196","keywords":"Competing-risk analysis, Epidemiological study, Incidence, Outcomes, Risk Factors, chronic kidney disease","pages":"174","bibtex":"@article{ayav_competing_2016,\n\ttitle = {Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the {EPIRAN} community-based study},\n\tvolume = {17},\n\tissn = {1471-2369},\n\tshorttitle = {Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5)},\n\turl = {https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-016-0379-3},\n\tdoi = {10.1186/s12882-016-0379-3},\n\tabstract = {BACKGROUND: Although chronic kidney disease (CKD) affects a growing number of people, epidemiologic data on incident CKD in the general population are scarce. Screening strategies to increase early CKD detection have been developed.\nMETHODS: From a community-based sample of 4,409 individuals residing in a well-defined geographical area, we determined the number of patients having a first serum creatinine value ≥1.7 mg/dL and present for at least 3 months that allowed us to calculate an annual incidence rate of CKD (stages 3 to 5). CKD (stages 3 to 5) was defined by estimated glomerular filtration rate (eGFR) {\\textless}60 mL/min/1.73 m(2). We also described the primary care, outcomes and risk factors associated with outcomes using competing risks analyses for these CKD patients.\nRESULTS: A total of 631 incident CKD patients (stages 3 to 5) were followed-up until the occurrence of death and dialysis initiation for more than 3 years. The annual incidence rate of CKD (stages 3 to 5) was estimated at 977.7 per million inhabitants. Analyses were performed on 514 patients with available medical data. During the study, 155 patients (30.2 \\%) were referred to a nephrologist, 193 (37.5 \\%) died and 58 (11.3 \\%) reached end-stage renal disease and initiated dialysis. A total of 139 patients (27.6 \\%) had a fast decline of their renal function, 92 (18.3 \\%) a moderate decline and the 272 remaining patients had a physiological decline (21.1 \\%) or a small improvement of their renal function (33.0 \\%). Predictors of death found in both Cox and Fine-Gray multivariable regression models included age at diagnosis, anemia, active neoplasia and chronic heart failure, but not a low glomerular filtration rate (GFR). Age at diagnosis, anemia and a low GFR were independently associated with dialysis initiation in Cox model, but anemia was not found to be a risk factor for dialysis initiation in Fine-Gray model.\nCONCLUSIONS: This large cohort study provided useful epidemiological data on incident CKD (stages 3 to 5) and stressed the need to improve the hands-on implementation of clinical practice guidelines for the evaluation and the management of CKD in primary care.},\n\tlanguage = {eng},\n\tnumber = {1},\n\tjournal = {BMC nephrology},\n\tauthor = {Ayav, Carole and Beuscart, Jean-Baptiste and Briançon, Serge and Duhamel, Alain and Frimat, Luc and Kessler, Michèle},\n\tmonth = nov,\n\tyear = {2016},\n\tpmid = {27846810},\n\tpmcid = {PMC5111196},\n\tkeywords = {Competing-risk analysis, Epidemiological study, Incidence, Outcomes, Risk Factors, chronic kidney disease},\n\tpages = {174},\n}\n\n","author_short":["Ayav, C.","Beuscart, J.","Briançon, S.","Duhamel, A.","Frimat, L.","Kessler, M."],"key":"ayav_competing_2016","id":"ayav_competing_2016","bibbaseid":"ayav-beuscart-brianon-duhamel-frimat-kessler-competingriskofdeathandendstagerenaldiseaseinincidentchronickidneydiseasestages3to5theepirancommunitybasedstudy-2016","role":"author","urls":{"Paper":"https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-016-0379-3"},"keyword":["Competing-risk analysis","Epidemiological study","Incidence","Outcomes","Risk Factors","chronic kidney disease"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/576834/collections/NYCBQQBB/items?key=MJNBdUsYThALl7viNVVbkecN&format=bibtex&limit=100","dataSources":["KcAAuaxski6XBszw2"],"keywords":["competing-risk analysis","epidemiological study","incidence","outcomes","risk factors","chronic kidney disease"],"search_terms":["competing","risk","death","end","stage","renal","disease","incident","chronic","kidney","disease","stages","epiran","community","based","study","ayav","beuscart","briançon","duhamel","frimat","kessler"],"title":"Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study","year":2016}